Table of Content

Open Access iconOpen Access

ARTICLE

High levels of circulating interleukin-10 in diabetic nephropathy patients

Jolanta Myśliwska1, K. Zorena1, E. Semetkowska-Jurkiewicz2, D. Rachoń1, H. Suchanek1, A. Myśliwski3

1 Department of Immunology, Medical University of Gdan´sk, ul. DVbinki 1, 80-210 Gdan´sk, Poland
2 Regional Diabetic Center, Medical University of Gdan´sk, Poland
3 Department of Histology, Medical University of Gdan´sk, Poland

* Corresponding Author: J. Myśliwska, email

European Cytokine Network 2005, 16(2), 117-122.

Abstract

Aims. The aim of our study was to analyse the level of circulating interleukin-10 (IL-10) and relate it to the grade of albuminuria in patients with diabetic nephropathy (DN) due to type 1 diabetes mellitus (DM). Since IL-10 has met the criteria for an anti-inflammatory and an immunosuppressive cytokine, its activity may be important for clinical outcome of DN. Methods. The IL-10 level was measured by ELISA in serum samples from thirty patients with DN due to type 1 DM, and compared with thirty patients with type 1 DM without DN and a control group of thirty, healthy, age- and sex-matched people. Results. We observed a greatly elevated concentration of circulating IL-10 in 30/30 DM patients with DN (mean 140 pg/mL ± 102), compared to DM patients without DN in whom IL-10 was detectable in only 11/30 patients (0.79 pg/mL ± 1.24), and the group of healthy people in whom IL-10 was detectable in only 3/30 donors (0.92 pg/mL ± 0.17). IL-10 appeared to be the strongest independent predictor of albuminuria, followed by HbA1c, diastolic blood pressure and DN duration. There was a positive correlation between the values of IL-10 and albuminuria in DM patients with DN. The patients in the fourth quartile of albuminuria had a distinctly higher concentration of IL-10 than those in the lower quartiles. Conclusions. The increased concentration of IL-10 in the serum samples from DM patients with DN seems to depend on the severity of the nephropathy. The excessive IL-10 production may indirectly contribute towards DN progression. On the other hand, it may explain the relatively long course of diabetic nephropathy.

Keywords

interleukin-10, type 1 diabetes mellitus, nephropathy

Cite This Article

APA Style
Myśliwska, J., Zorena, K., Semetkowska-Jurkiewicz, E., Rachoń, D., Suchanek, H. et al. (2005). High levels of circulating interleukin-10 in diabetic nephropathy patients. European Cytokine Network, 16(2), 117–122.
Vancouver Style
Myśliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachoń D, Suchanek H, Myśliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Network. 2005;16(2):117–122.
IEEE Style
J. Myśliwska, K. Zorena, E. Semetkowska-Jurkiewicz, D. Rachoń, H. Suchanek, and A. Myśliwski, “High levels of circulating interleukin-10 in diabetic nephropathy patients,” Eur. Cytokine Network, vol. 16, no. 2, pp. 117–122, 2005.



cc Copyright © 2005 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 36

    View

  • 29

    Download

  • 0

    Like

Share Link